This is important because shifts in fat distribution and in body composition that occur during the menopausal transition are associated with increased cardiometabolic risk factors, including elevated blood pressure, elevated low-density lipoprotein, and obesity
A pure GLP-1 agonist covers half the mechanism
A small drop of blood at the insertion point is normal
Lack of Consultation : By bypassing essential clinical consultations, a medical professional cannot ensure the medication is suitable for the individual, and GLP-1s are not suitable for everyone
All of these medications have different dosing schedules and frequencies
For most patients, GLP-1-related bloating improves after dose stabilization, typically within 4 weeks to several months